Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

A serum potassium level above 10 mmol/l in a patient predisposed to hypokalemia

Abstract

Background A 58-year-old man, previously diagnosed with Bartter's syndrome, presented with a short history of vomiting, diarrhea and weakness. He had severe hyperkalemia (serum potassium levels >10 mmol/l), which was successfully managed. Post hoc investigation suggested that the patient had Gitelman's rather than Bartter's syndrome.

Investigations Physical examination, urine and blood analyses, chest radiography, electrocardiogram, renal ultrasound, and genetic analysis focusing on the SLC12A3 gene, which encodes the thiazide-sensitive Na/Cl cotransporter.

Diagnosis Gitelman's syndrome and hyperkalemia secondary to acute renal failure plus exogenous potassium supplementation.

Management Intravenous calcium gluconate, insulin and dextrose administration. Temporary continuous venovenous hemodiafiltration. Genetic confirmation of the underlying molecular defect. Long-term treatment for Gitelman's syndrome with oral potassium and magnesium supplements and epithelial sodium channel-blocking drugs. Review of patient education regarding renal salt-wasting syndromes.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Changes in the patient's electrocardiogram during hospitalization.
Figure 2: A nephron in a patient with Gitelman's syndrome.

References

  1. Simon DB et al. (1996) Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet 12: 24–30

    CAS  PubMed  Google Scholar 

  2. Lemmink HH et al. (1998) Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int 54: 720–730

    CAS  PubMed  Google Scholar 

  3. De Jong JC et al. (2002) Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome. J Am Soc Nephrol 13: 1442–1448

    CAS  PubMed  Google Scholar 

  4. Bartter FC et al. (1962) Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis: a new syndrome. Am J Med 33: 811–828

    CAS  PubMed  Google Scholar 

  5. Gitelman HJ et al. (1966) A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 79: 221–235

    CAS  PubMed  Google Scholar 

  6. Bettinelli A and Tedeschi S (2003) Hypokalemia and hypomagnesemia of hereditary renal tubular origin: Bartter and Gitelman syndromes. Acta Biomed Ateneo Parmense 74: 163–167

    Google Scholar 

  7. Jeck N et al. (2005) Salt handling in the distal nephron: lessons learned from inherited human disorders. Am J Physiol Regul Integr Comp Physiol 288: R782–R795

    CAS  PubMed  Google Scholar 

  8. Bettinelli A et al. (1999) Magnesium supplementation in Gitelman syndrome. Pediatr Nephrol 13: 311–314

    CAS  PubMed  Google Scholar 

  9. Schachter AD et al. (1998) Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome. Pediatr Nephrol 12: 775–777

    CAS  PubMed  Google Scholar 

  10. Peters M et al. (2002) Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. Am J Med 112: 183–190

    PubMed  Google Scholar 

  11. Colussi G et al. (1994) Correction of hypokalemia with antialdosterone therapy in Gitelman's syndrome. Am J Nephrol 14: 127–135

    CAS  PubMed  Google Scholar 

  12. Bettinelli A et al. (1992) Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 120: 38–43

    CAS  PubMed  Google Scholar 

  13. Cruz DN et al. (2001) Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int 59: 710–717

    CAS  PubMed  Google Scholar 

  14. Simon DB et al. (1996) Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13: 183–188

    CAS  PubMed  Google Scholar 

  15. Simon DB et al. (1996) Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet 14: 152–156

    CAS  PubMed  Google Scholar 

  16. Simon DB et al. (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17: 171–178

    CAS  PubMed  Google Scholar 

  17. Birkenhager R et al. (2001) Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29: 310–314

    CAS  PubMed  Google Scholar 

  18. Watanabe S et al. (2002) Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360: 692–694

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fiona E Karet.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phillips, D., Ahmad, K., Waller, S. et al. A serum potassium level above 10 mmol/l in a patient predisposed to hypokalemia. Nat Rev Nephrol 2, 340–346 (2006). https://doi.org/10.1038/ncpneph0201

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0201

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing